학술논문

Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program
Document Type
article
Source
Journal of the National Cancer Institute. 115(2)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Oncology and Carcinogenesis
Prevention
Prostate Cancer
Cancer
Urologic Diseases
Clinical Research
Genetics
Aging
Detection
screening and diagnosis
4.1 Discovery and preclinical testing of markers and technologies
Good Health and Well Being
Humans
Male
Aged
Prostatic Neoplasms
Veterans
Retrospective Studies
Prostate-Specific Antigen
Cohort Studies
Early Detection of Cancer
Oncology & Carcinogenesis
Oncology and carcinogenesis
Language
Abstract
BackgroundGenetic scores may provide an objective measure of prostate cancer risk and thus inform screening decisions. We evaluated whether a polygenic hazard score based on 290 genetic variants (PHS290) is associated with prostate cancer risk in a diverse population, including Black men, who have higher average risk of prostate cancer death but are often treated as a homogeneously high-risk group.MethodsThis was a retrospective analysis of the Million Veteran Program, a national, population-based cohort study of US military veterans conducted 2011-2021. Cox proportional hazards analyses tested for association of genetic and other risk factors (including self-reported race and ethnicity and family history) with age at death from prostate cancer, age at diagnosis of metastatic (nodal or distant) prostate cancer, and age at diagnosis of any prostate cancer.ResultsA total of 590 750 male participants were included. Median age at last follow-up was 69 years. PHS290 was associated with fatal prostate cancer in the full cohort and for each racial and ethnic group (P